N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
作者信息
Goswami Manish, Jawali Narendra
出版信息
Antimicrob Agents Chemother. 2010 Aug;54(8):3529-30. doi: 10.1128/AAC.00710-10. Epub 2010 Jun 14.
Abstract
摘要
相似文献
1
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Antimicrob Agents Chemother. 2010 Aug;54(8):3529-30. doi: 10.1128/AAC.00710-10. Epub 2010 Jun 14.
2
N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.
Microb Pathog. 2017 Apr;105:145-152. doi: 10.1016/j.micpath.2017.02.030. Epub 2017 Feb 22.
3
Differences in determining in vitro tigecycline susceptibility according to the agar medium used.
J Chemother. 2010 Apr;22(2):137-8. doi: 10.1179/joc.2010.22.2.137.
4
Increased susceptibility to antibiotics in gram-negative and gram-positive pathogens, including Pseudomonas aeruginosa, at lower temperature: is antibiotic resistance reversal possible?
Br J Biomed Sci. 2013;70(4):173-4. doi: 10.1080/09674845.2013.11669952.
5
Antibiotic sensitivity still prevails in Norwegian blood culture isolates.
Int J Antimicrob Agents. 2001 Aug;18(2):99-106. doi: 10.1016/s0924-8579(01)00364-8.
6
A culture medium for screening 16S rRNA methylase-producing pan-aminoglycoside resistant Gram-negative bacteria.
Diagn Microbiol Infect Dis. 2018 Jun;91(2):118-122. doi: 10.1016/j.diagmicrobio.2018.01.026. Epub 2018 Feb 3.
7
[Effect of bile on bacterial sensitivity to antibiotics].
Antibiot Med Biotekhnol. 1985 Mar;30(3):232-3.
8
High incidence of plasmid-mediated quinolone resistance (PMQR) genes among antibiotic-resistant Gram-negative bacteria from patients of the Lithuanian National Cancer Center.
Infect Dis (Lond). 2019 Jun;51(6):471-474. doi: 10.1080/23744235.2019.1591637. Epub 2019 Mar 25.
9
Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
J Antimicrob Chemother. 2011 Jun;66(6):1374-82. doi: 10.1093/jac/dkr103. Epub 2011 Mar 24.
10
A simple blood-culture bacterial pellet preparation for faster accurate direct bacterial identification and antibiotic susceptibility testing with the VITEK 2 system.
J Med Microbiol. 2013 May;62(Pt 5):773-777. doi: 10.1099/jmm.0.049361-0. Epub 2013 Jan 17.
引用本文的文献
1
Influence of N-Acetyl-L-Cysteine on the Pharmacokinetics and Antibacterial Activity of Marbofloxacin in Chickens.
Antibiotics (Basel). 2025 Apr 10;14(4):393. doi: 10.3390/antibiotics14040393.
2
Synergistic action of mucoactive drugs and phages against and .
Microbiol Spectr. 2025 Mar 4;13(3):e0160124. doi: 10.1128/spectrum.01601-24. Epub 2025 Feb 6.
3
N-Acetyl cysteine exhibits antimicrobial and anti-virulence activity against Salmonella enterica.
PLoS One. 2025 Jan 7;20(1):e0313508. doi: 10.1371/journal.pone.0313508. eCollection 2025.
4
Liposomal Drug Delivery against Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.
Pharmaceutics. 2024 Aug 26;16(9):1123. doi: 10.3390/pharmaceutics16091123.
5
N-acetylcysteine promotes doxycycline resistance in the bacterial pathogen .
Virulence. 2024 Dec;15(1):2399983. doi: 10.1080/21505594.2024.2399983. Epub 2024 Sep 17.
6
Cell free extract-mediated biogenic synthesis of ZnONPs and their application with kanamycin as a bactericidal combination.
World J Microbiol Biotechnol. 2023 Oct 9;39(12):334. doi: 10.1007/s11274-023-03777-z.
7
Effect of N-Acetyl-L-cysteine on Activity of Doxycycline against Biofilm-Forming Bacterial Strains.
Antibiotics (Basel). 2023 Jul 14;12(7):1187. doi: 10.3390/antibiotics12071187.
8
In Vitro Antimicrobial Activity of N-Acetylcysteine against Pathogens Most Commonly Associated with Infectious Keratitis in Dogs and Cats.
Antibiotics (Basel). 2023 Mar 11;12(3):559. doi: 10.3390/antibiotics12030559.
9
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant and .
Antibiotics (Basel). 2022 Feb 10;11(2):225. doi: 10.3390/antibiotics11020225.
10
N-Acetylcysteine as Adjuvant Therapy for COVID-19 - A Perspective on the Current State of the Evidence.
J Inflamm Res. 2021 Jul 6;14:2993-3013. doi: 10.2147/JIR.S306849. eCollection 2021.
本文引用的文献
1
High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease.
Clin Drug Investig. 2005;25(6):401-8. doi: 10.2165/00044011-200525060-00005.
2
Glutathione-mediated augmentation of beta-lactam antibacterial activity against Escherichia coli.
J Antimicrob Chemother. 2007 Jul;60(1):184-5. doi: 10.1093/jac/dkm121. Epub 2007 May 4.
3
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
Antimicrob Agents Chemother. 2007 Mar;51(3):1119-22. doi: 10.1128/AAC.00779-06. Epub 2007 Jan 8.
4
Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules.
Curr Med Chem. 2006;13(15):1749-55. doi: 10.2174/092986706777452542.
5
Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms.
Int J Antimicrob Agents. 2003 Oct;22 Suppl 2:95-100. doi: 10.1016/s0924-8579(03)00232-2.
6
N-acetylcysteine.
Altern Med Rev. 2000 Oct;5(5):467-71.
7
Effect of L-cysteine on the activity of penicillin antibiotics against Clostridium difficile.
Antimicrob Agents Chemother. 1985 Mar;27(3):419-21. doi: 10.1128/AAC.27.3.419.
Zotero 插件